Lee et al. [60] identified that S100A14 inhibits STAT3-mediated PD-1 expression and the phenotype of tumor stem cells, promotes CD8+ T-cell-mediated cytotoxicity, inhibits immune evasion, and restores chemosensitivity. The gene discussed is S100A14; the disease is neoplasm.